Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
FeaturedGeneticsPsychology·November 28, 2016·5 min readSmall RNA Identified That Offers Clues for Quieting the ‘Voices’ of SchizophreniaA new study identifies a microRNA that may be essential to restoring normal function in a brain circuit associated with auditory hallucinations in schizophrenia.Read More
Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
